Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3335606
Max Phase: Preclinical
Molecular Formula: C18H21N5O4S
Molecular Weight: 403.46
Molecule Type: Small molecule
Associated Items:
ID: ALA3335606
Max Phase: Preclinical
Molecular Formula: C18H21N5O4S
Molecular Weight: 403.46
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Nc1nc2[nH]c(CCCc3ccc(C(=O)NCCCC(=O)O)s3)cc2c(=O)[nH]1
Standard InChI: InChI=1S/C18H21N5O4S/c19-18-22-15-12(16(26)23-18)9-10(21-15)3-1-4-11-6-7-13(28-11)17(27)20-8-2-5-14(24)25/h6-7,9H,1-5,8H2,(H,20,27)(H,24,25)(H4,19,21,22,23,26)
Standard InChI Key: LBARNPDPBYSBEF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 403.46 | Molecular Weight (Monoisotopic): 403.1314 | AlogP: 1.66 | #Rotatable Bonds: 9 |
Polar Surface Area: 153.96 | Molecular Species: ACID | HBA: 6 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 4.14 | CX Basic pKa: 4.80 | CX LogP: 0.78 | CX LogD: -1.34 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.34 | Np Likeness Score: -0.68 |
1. Golani LK, George C, Zhao S, Raghavan S, Orr S, Wallace A, Wilson MR, Hou Z, Matherly LH, Gangjee A.. (2014) Structure-activity profiles of novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolates with modified amino acids for cellular uptake by folate receptors α and β and the proton-coupled folate transporter., 57 (19): [PMID:25234128] [10.1021/jm501113m] |
Source(1):